Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans
Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6β-hydroxycortisol
In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet
Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2
Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans
Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19
MDR1 reference sequence and reference function
How drug prices are set: An example from the perspective of a social security association
Selective monoclonal versus polyclonal antibodies for induction of immunosuppression in lung recipients
A message from the ASCPT Membership Committee Chairperson